Black Bird Biotech Inc logo

Black Bird Biotech Inc

$ 0.00 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 326.00K
Enterprise V:
$ 915.00K
Volume:
9.53M
Avg Vol (2M):
3.14M
Volume:
9.53M
Market Cap $:
326.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
3.14M
Enterprise Value $:
915.00K
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.1
Equity-to-Asset -3.89
Debt-to-Equity -1
Debt-to-EBITDA -0.37
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -74.25
Distress
Grey
Safe
Beneish M-Score -35.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -81.7
3-Year EPS without NRI Growth Rate -108
3-Year FCF Growth Rate -58.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.78
9-Day RSI 33.45
14-Day RSI 34.04
6-1 Month Momentum % -48.15
12-1 Month Momentum % -72.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.19
Quick Ratio 0.08
Cash Ratio 0.08
Days Inventory 494.25
Days Sales Outstanding 20.19
Days Payable 292

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -51.9

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 34.04
Operating Margin % -1931.91
Net Margin % -2451.06
ROE % -3789.47
ROA % -437.52
ROIC % -317.7
ROC (Joel Greenblatt) % -738.67
ROCE % -3100

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.46
EV-to-EBITDA -0.49
EV-to-Revenue 9.2
EV-to-FCF -0.79
Earnings Yield (Greenblatt) % -217.39

Financials

BBBT's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:BBBT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.094
EPS (TTM) ($) -0.009
Beta 3.94
Volatility % 75.31
14-Day RSI 34.04
14-Day ATR ($) 0.000626
20-Day SMA ($) 0.00236
12-1 Month Momentum % -72.19
52-Week Range ($) 0.0012 - 0.024
Shares Outstanding (Mil) 250.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Black Bird Biotech Inc Filings

Document Form Filing Date
No Filing Data

Black Bird Biotech Inc Analysis

Share your research

Headlines

See More
No news.